Literature DB >> 19481034

Feline herpesvirus infection. ABCD guidelines on prevention and management.

Etienne Thiry1, Diane Addie, Sándor Belák, Corine Boucraut-Baralon, Herman Egberink, Tadeusz Frymus, Tim Gruffydd-Jones, Katrin Hartmann, Margaret J Hosie, Albert Lloret, Hans Lutz, Fulvio Marsilio, Maria Grazia Pennisi, Alan D Radford, Uwe Truyen, Marian C Horzinek.   

Abstract

OVERVIEW: Feline viral rhinotracheitis, caused by feline herpesvirus (FHV), is an upper respiratory tract disease that is often associated with feline calicivirus and bacteria. In most cats, FHV remains latent after recovery, and they become lifelong virus carriers. Stress or corticosteroid treatment may lead to virus reactivation and shedding in oronasal and conjunctival secretions. INFECTION: Sick cats shed FHV in oral, nasal and conjunctival secretions; shedding may last for 3 weeks. Infection requires direct contact with a shedding cat. DISEASE SIGNS: Feline herpesvirus infections cause acute rhinitis and conjunctivitis, usually accompanied by fever, depression and anorexia. Affected cats may also develop typical ulcerative, dendritic keratitis. DIAGNOSIS: Samples consist of conjunctival, corneal or oropharyngeal swabs, corneal scrapings or biopsies. It is not recommended that cats recently vaccinated with a modified-live virus vaccine are sampled. Positive PCR results should be interpreted with caution, as they may be produced by low-level shedding or viral latency. DISEASE MANAGEMENT: 'Tender loving care' from the owner, supportive therapy and good nursing are essential. Anorexic cats should be fed blended, highly palatable food - warmed up if required. Mucolytic drugs (eg, bromhexine) or nebulisation with saline may offer relief. Broad-spectrum antibiotics should be given to prevent secondary bacterial infections. Topical antiviral drugs may be used for the treatment of acute FHV ocular disease. The virus is labile and susceptible to most disinfectants, antiseptics and detergents. VACCINATION RECOMMENDATIONS: Two injections, at 9 and 12 weeks of age, are recommended, with a first booster 1 year later. Boosters should be given annually to at-risk cats. For cats in low-risk situations (eg, indoor-only cats), 3-yearly intervals suffice. Cats that have recovered from FHV-associated disease are usually not protected for life against further disease episodes; vaccination of recovered cats is therefore recommended.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19481034      PMCID: PMC7129359          DOI: 10.1016/j.jfms.2009.05.003

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  34 in total

1.  A study of feline upper respiratory tract disease with reference to prevalence and risk factors for infection with feline calicivirus and feline herpesvirus.

Authors:  S H Binns; S Dawson; A J Speakman; L E Cuevas; C A Hart; C J Gaskell; K L Morgan; R M Gaskell
Journal:  J Feline Med Surg       Date:  2000-09       Impact factor: 2.015

2.  Use of serologic tests to predict resistance to feline herpesvirus 1, feline calicivirus, and feline parvovirus infection in cats.

Authors:  Michael R Lappin; Janet Andrews; Dan Simpson; Wayne A Jensen
Journal:  J Am Vet Med Assoc       Date:  2002-01-01       Impact factor: 1.936

3.  Relative sensitivity of polymerase chain reaction assays used for detection of feline herpesvirus type 1 DNA in clinical samples and commercial vaccines.

Authors:  David J Maggs; Heather E Clarke
Journal:  Am J Vet Res       Date:  2005-09       Impact factor: 1.156

Review 4.  Update on pathogenesis, diagnosis, and treatment of feline herpesvirus type 1.

Authors:  David J Maggs
Journal:  Clin Tech Small Anim Pract       Date:  2005-05

5.  Survival of equine herpesvirus-4, feline herpesvirus-1, and feline calicivirus in multidose ophthalmic solutions.

Authors:  Eric S Storey; Paul A Gerding; Gail Scherba; David J Schaeffer
Journal:  Vet Ophthalmol       Date:  2002-12       Impact factor: 1.644

6.  Enzyme-linked immunosorbent assay for detection of feline herpesvirus 1 IgG in serum, aqueous humor, and cerebrospinal fluid.

Authors:  D A Dawson; J Carman; J Collins; S Hill; M R Lappin
Journal:  J Vet Diagn Invest       Date:  1998-10       Impact factor: 1.279

7.  Efficacy of oral supplementation with L-lysine in cats latently infected with feline herpesvirus.

Authors:  David J Maggs; Mark P Nasisse; Philip H Kass
Journal:  Am J Vet Res       Date:  2003-01       Impact factor: 1.156

8.  Duration of serologic response to three viral antigens in cats.

Authors:  Douglas E Mouzin; Marianne J Lorenzen; John D Haworth; Vickie L King
Journal:  J Am Vet Med Assoc       Date:  2004-01-01       Impact factor: 1.936

9.  Detection of Chlamydophila felis and feline herpesvirus by multiplex real-time PCR analysis.

Authors:  Chris Helps; Nicky Reeves; Kathy Egan; Pam Howard; Dave Harbour
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

10.  Common virus infections in cats, before and after being placed in shelters, with emphasis on feline enteric coronavirus.

Authors:  N C Pedersen; R Sato; J E Foley; A M Poland
Journal:  J Feline Med Surg       Date:  2004-04       Impact factor: 2.015

View more
  33 in total

1.  Pneumonia and gastritis in a cat caused by feline herpesvirus-1.

Authors:  Glenna F McGregor; Karen Sheehan; Elemir Simko
Journal:  Can Vet J       Date:  2016-02       Impact factor: 1.008

2.  Histologic and molecular correlation in shelter cats with acute upper respiratory infection.

Authors:  Rachel E Burns; Denae C Wagner; Christian M Leutenegger; Patricia A Pesavento
Journal:  J Clin Microbiol       Date:  2011-05-11       Impact factor: 5.948

3.  Felid herpesvirus 1 as a causative agent of severe nonsuppurative meningoencephalitis in a domestic cat.

Authors:  Aline S Hora; Paloma O Tonietti; Juliana M Guerra; Maiara C Leme; Hilda F J Pena; Paulo C Maiorka; Paulo E Brandão
Journal:  J Clin Microbiol       Date:  2012-11-14       Impact factor: 5.948

4.  Prevalence of feline herpesvirus-1, feline calicivirus, Chlamydia felis, and Bordetella bronchiseptica in a population of shelter cats on Prince Edward Island.

Authors:  Julie Walter; Peter Foley; Carmencita Yason; Raphael Vanderstichel; Anne Muckle
Journal:  Can J Vet Res       Date:  2020-07       Impact factor: 1.310

5.  Genomic, Recombinational and Phylogenetic Characterization of Global Feline Herpesvirus 1 Isolates.

Authors:  Andrew C Lewin; Aaron W Kolb; Gillian J McLellan; Ellison Bentley; Kristen A Bernard; Sandra P Newbury; Curtis R Brandt
Journal:  Virology       Date:  2018-03-30       Impact factor: 3.616

6.  Feline Herpesvirus 1 US3 Blocks the Type I Interferon Signal Pathway by Targeting Interferon Regulatory Factor 3 Dimerization in a Kinase-Independent Manner.

Authors:  Jin Tian; Yongxiang Liu; Xiaoxiao Liu; Xue Sun; Jikai Zhang; Liandong Qu
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

7.  Broad anti-herpesviral activity of α-hydroxytropolones.

Authors:  Shannon D Dehghanpir; Claire H Birkenheuer; Kui Yang; Ryan P Murelli; Lynda A Morrison; Stuart F J Le Grice; Joel D Baines
Journal:  Vet Microbiol       Date:  2017-12-27       Impact factor: 3.293

8.  Presumed acquired dynamic pectus excavatum in a cat.

Authors:  Chee Kin Lim; Hock Gan Heng; Lynn F Guptill
Journal:  Can Vet J       Date:  2021-07       Impact factor: 1.008

9.  A 5-year retrospective study of canine and feline patients referred to an isolation unit for infectious diseases.

Authors:  Catarina Paulo; Inês Machado; Helena Carvalho; Joana Gomes; Ana Deodato Mota; Luís Tavares; Virgílio Almeida; Solange Gil
Journal:  Vet Rec Open       Date:  2021-04-05

10.  A novel Filobacterium sp can cause chronic bronchitis in cats.

Authors:  Martina Načeradská; Sona Pekova; Patrizia Danesi; Tommaso Furlanello; Roberta Calleo; Patricia Martin; Fumio Ike; Richard Malik
Journal:  PLoS One       Date:  2021-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.